ReviewDisease models & mechanisms2026
Leveraging organoid models to understand mechanisms of viral infections and immunity in bats.
Review in Disease models & mechanisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Enhancing the in vitro architecture of human disease.Disease models & mechanisms · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Bats are important reservoir hosts for zoonotic viruses owing to their unusual ability to avoid development of clinical disease and pathological lesions upon viral infection. Research efforts to understand the unique responses of bats to viral infection have been limited by the vast number of bat species and the lack of accessible experimental model systems. Over the past 5 years, organoid models, which are long-term cultures of primary cells, have been developed from gastrointestinal, respiratory and kidney tissues of multiple fruit-eating and insectivorous bats. Compared with human organoids, bat organoids showed increased expression of type I and type III interferon genes, other antiviral genes and complement genes at baseline and in response to viral stimulation. Bat organoids generally showed strong upregulation of interferon genes and interferon-stimulated genes in response to viruses. Conversely, the ability of bat organoids to support viral replication was dependent on the virus, tissue type and bat species. Overall, the recent progress in the field demonstrates the potential of organoids to serve as relevant models for exploring species- and tissue-specific responses to viruses in bats.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.